» Articles » PMID: 39975340

Protein Sequence Editing Defines Distinct and Overlapping Functions of SKN-1A/Nrf1 and SKN-1C/Nrf2

Overview
Journal bioRxiv
Date 2025 Feb 20
PMID 39975340
Authors
Affiliations
Soon will be listed here.
Abstract

The Nrf/NFE2L family of transcription factors regulates redox balance, xenobiotic detoxification, metabolism, proteostasis, and aging. Nrf1/NFE2L1 is primarily responsible for stress-responsive upregulation of proteasome subunit genes and is essential for adaptation to proteotoxic stress. Nrf2/NFE2L2 is mainly involved in activating oxidative stress responses and promoting xenobiotic detoxification. Nrf1 and Nrf2 contain very similar DNA binding domains and can drive similar transcriptional responses. In , a single gene, , encodes distinct protein isoforms, SKN-1A and SKN-1C, that function analogously to mammalian Nrf1 and Nrf2, respectively, and share an identical DNA binding domain. Thus, the extent to which SKN-1A/Nrf1 and SKN-1C/Nrf2 functions are distinct or overlapping has been unclear. Regulation of the proteasome by SKN-1A/Nrf1 requires post-translational conversion of N-glycosylated asparagine residues to aspartate by the PNG-1/NGLY1 peptide:N-glycanase, a process we term 'sequence editing'. Here, we reveal the consequences of sequence editing for the transcriptomic output of activated SKN-1A. We confirm that activation of proteasome subunit genes is strictly dependent on sequence editing. In addition, we find that sequence edited SKN-1A can also activate genes linked to redox homeostasis and xenobiotic detoxification that are also regulated by SKN-1C, but the extent of these genes' activation is antagonized by sequence editing. Using mutant alleles that selectively inactivate either SKN-1A or SKN-1C, we show that both isoforms promote optimal oxidative stress resistance, acting as effectors for distinct signaling pathways. These findings suggest that sequence editing governs SKN-1/Nrf functions by tuning the SKN-1A/Nrf1 regulated transcriptome.

References
1.
Hasegawa K, Miwa J . Genetic and cellular characterization of Caenorhabditis elegans mutants abnormal in the regulation of many phase II enzymes. PLoS One. 2010; 5(6):e11194. PMC: 2887452. DOI: 10.1371/journal.pone.0011194. View

2.
Tomlin F, Gerling-Driessen U, Liu Y, Flynn R, Vangala J, Lentz C . Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity. ACS Cent Sci. 2017; 3(11):1143-1155. PMC: 5704294. DOI: 10.1021/acscentsci.7b00224. View

3.
Tullet J, Hertweck M, An J, Baker J, Yun Hwang J, Liu S . Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell. 2008; 132(6):1025-38. PMC: 2367249. DOI: 10.1016/j.cell.2008.01.030. View

4.
Dirac-Svejstrup A, Walker J, Faull P, Encheva V, Akimov V, Puglia M . DDI2 Is a Ubiquitin-Directed Endoprotease Responsible for Cleavage of Transcription Factor NRF1. Mol Cell. 2020; 79(2):332-341.e7. PMC: 7369636. DOI: 10.1016/j.molcel.2020.05.035. View

5.
Mayer C, Riera-Ponsati L, Kauppinen S, Klitgaard H, Erler J, Hansen S . Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications. Front Pharmacol. 2024; 15:1437939. PMC: 11306042. DOI: 10.3389/fphar.2024.1437939. View